Content area

|

Parent satisfaction and symptom relief in children with otitis media undergoing tympanostomy tube insertion

Authors
Lene Dahl Siggaard1, Thomas Qvist Barrett2, Michael Lüscher3, Peter Koefoed Tingsgaard4 & Preben Homøe5 1) Department of Otorhinolaryngology, Aalborg University Hospital2) ENT Private Clinic, Randers3) ENT Private Clinic, Aarhus4) ENT Private Clinic, Slagelse5) Department of Otorhinolaryngology and Maxillofacial Surgery, Zealand University Hospital, Køge, Denmark

Dan Med J 2019;66(9):A5567

ABSTRACT

INTRODUCTION: The objective of this study was to investigate parent satisfaction and symptom relief in children younger than 12 years undergoing tympanostomy tube (TT) insertion for otitis media (OM) using electronic patient-reported outcome (ePRO) data in private ear-nose & throat (ENT) practice settings.

METHODS: A total of 3,553 children aged 0-11 years and registered in the Danish ENT Specialists Organisation (DØNHO) database were included. Following parental consent to participate, we e-mailed a pre-surgical questionnaire two days prior to surgery. Follow-up questionnaires were sent one, three, six, nine and 12 months after surgery. The pre-operative questionnaire collected information on symptom duration, number of acute OM (AOM) episodes within one year before TT insertion and ear-related symptoms. The post-operative questionnaires collected information on symptom relief, number of AOM episodes and parental satisfaction.

RESULTS : Pre- and post-operative questionnaires from 2,462 children were eligible for complete analysis. Before surgery, 89.8% of parents reported a symptom duration of three months or longer and/or recurrent AOM (RAOM). Complete symptom regression was reported in more than half of the children post-operatively. For the rest, significant symptom relief was reported 1-12 months following TT insertion. Parent satisfaction rose from 94.8% to 97.2% in the course of the observation period.

CONCLUSIONS: We report a consistent, high rate of symptom relief 1-12 months following TT insertion in children < 12 years of age. Furthermore, parental satisfaction throughout the 12-month observation period was compelling.

FUNDING: none.

TRIAL REGISTRATION: The database was approved by the Danish Data Protection Agency as a private, clinical database (no. 2016-42-3152). According to Danish law, approval by the Danish Research Ethics Committee system was not necessary.

Otitis media (OM) is common in children. A previous study shows that approximately 60% of Danish preschool children experience at least one episode of OM [1]. The self-limiting nature of OM often makes treatment superfluous. However, in some children, recurrent acute OM (RAOM) and/or chronic OM with effusion (COME) causes prolonged symptoms, e.g. hearing problems, disrupted sleep, recurrent fever periods, earache, ear secretion and delayed speech development [2, 3].

Tympanostomy tube (TT) insertion is a well-established treatment for RAOM and/or COME. Earlier studies have explored both the short-term and long-term effectiveness of TT insertion without providing exact, strong evidence for the current treatment regime for children with OM [4-8]. A study from 2007 investigating long-term effects of TT insertion in children with COME below three years of age showed no developmental improvement or long-term benefits at 9-11 years of age [4]. Other studies show that TT insertion improves hearing and quality of life (QOL) the first months post-operatively in children with COME, suggesting short-term symptom relief after TT insertion [5, 6]. Although several QOL analyses of patients treated with TT insertion for COME, RAOM or both have been presented, [7, 8] controversy about correct surgical management of OM remains.

Electronic patient-reported outcome (ePRO) data have gained considerable scientific attention as an effective, time-efficient and accurate tool for assessing treatment outcomes [9]. To our knowledge, ePRO data have not yet been applied in children undergoing TT insertion for OM.

We here aimed to investigate the parent-perceived treatment effect of and satisfaction with TT insertion in children with OM by using ePRO data in private ENT practice settings.

METHODS

This study was a prospective, observational, multicentre study based on ePRO data from the Danish ENT Specialists Organisation (DØNHO) database, which was established in early 2017. A total of 17 Danish private ENT clinics, comprising 26 ENT specialists, have joined the database, registering patients offered TT insertion. The participating ENT clinics are geographically located in all five Danish regions. Inclusion of patients into the database is on-going, and the project can, if needed, prospectively be expanded to all 160 private ear-nose and throat (ENT) specialists in Denmark. The present study reports on the results from the first 3,553 patients enrolled from March 2017 to August 2018.

Inclusion and exclusion criteria

The caregiver of every child below 12 years of age scheduled for TT insertion in general anaesthesia was offered study inclusion. If one or more of the six exclusion criteria were met (children aged ≥ 12 years, parents with no e-mail address, insufficient language or cognitive capabilities, no wish to participate, or illiterate parents), the child was registered anonymously and excluded immediately. Data were encrypted and anonymously stored electronically in the database.

Participation

At the pre-operative examination, parents were given information about the study. Following parental consent to participate, we e-mailed a pre-operative questionnaire to the parent two days before surgery. Post-operative questionnaires were sent one month after surgery and then every three months until completion of the two-year follow-up period. The parents completed the questionnaires at home without interference from the doctor or the clinic staff. Routines regarding surgical procedure and post-operative follow-up and treatment remained unchanged. In this initial report of results, we include data covering the first 12 months after TT insertion.

Contents of the Danish National Tympanostomy Tube Insertion Questionnaires

Prior to surgery, the parents were asked for information on caregiver’s labour market absence, occurrence of ear-related problems, symptom duration and number of AOM episodes within one year prior to TT insertion. The post-operative follow-up questionnaires obtained information on relief from and remaining pre-operative symptoms, number of AOM episodes, AOM treatment, parental satisfaction and caregiver’s labour market absence. In this study, we focussed on pre- and post-operative symptoms and parental satisfaction following TT insertion.

The Danish National Tympanostomy Tube Insertion Questionnaires (DANTIQ) were developed by a group of ENT specialists and has undergone validation as reported elsewhere [10].

Completeness of inclusion

To investigate study inclusion completeness, three clinics manually and retrospectively examined a total of 162 consecutive children younger than 12 years scheduled for TT insertion in general anaesthesia (GA) in the survey period. Among these, 149 children (92%) were included in the database. Non-participation was due to unregistered exclusion or incomplete registration by clinic staff.

Non-responders

Age and gender composition were analysed in the group of children whose parents did not answer the pre-operative questionnaire and compared with the responder group.

Statistical analysis

The Biostatistical Advisory Service at the University Hospital in Aarhus (BIAS) checked and validated all data calculations and performed all statistical analyses. Confidence intervals (CI) for proportions were calculated, and the chi-squared test was used for inter-group comparison. The change in symptom severity was calculated for those with paired observations pre- and post-operatively and the reduction in probability of each symptom was tested with McNemar’s test. A two-sided p value <0.05 was considered statistically significant.

Trial registration: The database was approved by the Danish Data Protection Agency as a private, clinical database (no. 2016-42-3152). According to Danish law, approval by the Danish Research Ethics Committee system was not necessary.

RESULTS

A total of 3,553 children younger than 12 years were registered in the database between March 2017 and August 2018. Baseline characteristics are shown in
Table 1. For 808 children, pre-operative questionnaires were unanswered. A total of 283 children needed TT re-insertion and were re-registered in the database during the observation period. The need for TT re-insertion was considered due to symptom relapse of a pre-operatively registered symptom history. Hence, a full pre-operative symptom profile was not re-registered, and re-entries were therefore excluded. The remaining 2,462 pre-operative questionnaires were adequately answered and eligible for analysis for the observation period. The pre-operative response rate was 75.3% (95% confidence interval (CI): 73.8; 76.8). Post-operative response rates are shown in Table 2. Non-responder analysis showed no significant gender difference between participants and non-participants. The age of non-participants was significantly higher (1.06 times (95% CI: 1.007; 1.109)) than that of participants.

Parents spent a mean two minutes and 22 seconds completing the pre-operative questionnaire and less than one minute completing each questionnaire post-operatively. The private clinics spent an average of 16 seconds on manual registration and inclusion of a patient in the database, and after registration was completed, only three seconds extra on potential exclusion. This did not cover time spent by the clinic staff to inform parents about database inclusion, nor the time spent by ENT specialists on feedback or analyses of their own clinic-specific data.

Pre-surgical results

Table 1 shows symptom duration before TT insertion. In all, 89.8% of TT insertions were in accordance with the Danish National Clinical Guideline (NCG) definition of COME and RAOM. The median symptom duration interval was 6-12 months. Symptom profiles of the group of children deviating from guideline recommendation before TT insertion were not analysed separately. The most frequent pre-operative parent-reported symptoms were disrupted sleep and ear tugging, both of which were present in two thirds of the children (see Figure 1).

Post-surgical results

The pre- and post-operative symptom severity is illustrated in Figure 1. More than half of the children experienced complete symptom regression post-operatively. For the rest, either partial, no or unknown symptom regression was reported, and the severity of remaining symptoms was re-registered (see Table 2). Immediate, significant symptom relief was reported for earache/ear discomfort, hearing loss, interrupted sleep, delayed language development, AOM with or without effusion and ear tugging already at the one-month follow-up after TT insertion (p < 0.001). Results are specified in Figure 2. Data at the six-month follow-up are not presented here, but showed the same significance in symptom relief for all symptoms presented. Post-operative parent satisfaction is presented in Table 2.

DISCUSSION

This study is among the largest yet to report the outcome of TT insertion in patients with OM using ePRO data. We present the first results of 3,553 children. Our main results show significant short-term symptom relief up to 12 months after TT insertion in children with OM below 12 years of age. Most parents reported a symptom duration of three months or longer and/or RAOM for up to one year before TT insertion. This is in accordance with the Danish NCG. Symptoms of COME and RAOM may differ according to age. However, the results are calculated as individual symptom relief and the median age is 22 months (range 4-142 months). Therefore, age differences in symptoms in this study are of minor concern.

In all, 94.8% of the parents were satisfied with the TT insertion in their child one month post-operatively. Parent satisfaction remained compellingly high throughout the entire 12-month observation period. Based on these data, TT insertion seems to have a substantial short-term effect in children with OM.

ePRO data have shown significant strength for monitoring treatment effects [11, 12]. In the present study, questionnaires were sent electronically at specific pre-defined intervals via an automated software platform to facilitate parental participation. A minimum of time was spent on patient registration in the database by the ENT clinic staff, and no extra clinical examinations were needed, making data collection both swift, easily accessible, time efficient and cost beneficial. This has allowed the database to grow at a tremendous speed, providing us with a large body of data.

However, the database does not report on clinical ENT specialists’ assessments and exams, tympanometry findings and hearing threshold measurements. Although parent-provided information is essential to the overall assessment, private ENT specialists rely heavily on their objective findings as well when assessing the treatment effect of TT insertion. Furthermore, our study is susceptible to response-biased parents who prefer to have the procedure performed on their child. Even so, we believe that the quantity of ePRO data in this study carries considerable strength, making it a promising and sustainable tool for outcome monitoring in patients with OM undergoing TT insertion.

Earlier studies have investigated parent-perceived treatment effect after TT insertion in Danish children with COME and/or RAOM. A study among 24 private ENT specialists from 2010 investigated guideline adherence and parental satisfaction following TT insertion. A total of 426 children aged 0-6 years with OM offered first-time TT insertion were included. Parents and participating ENT specialists answered pre- and three-month post-operative questionnaires. Interrupted sleep and earache before TT insertion were reported in 60% of the children and hearing loss in 33%. Significant post-operative symptom regression was found, and 96% of the parents were satisfied with their child’s TT insertion [13]. Another study from 2015 investigating QOL differences among diagnostic subgroups of Danish children receiving TT for OM using the Otitis Media-6 questionnaire found significant QOL improvements in 491 children with RAOM, COME or both at 1-18 month follow-up after TT insertion [14]. As our study population was comparable in regard to age, gender composition and symptom burden prior to TT insertion, we believe that our data support these previous findings and vice versa.

Danish and international clinical guidelines mainly focus on child hearing when outlining proper use of TT insertion [15-17]. Likewise, changes in hearing thresholds have been used in various studies to evaluate the treatment effect of TT insertion in children with COME [18, 19]. An international consensus guideline from 2017 confirms that COME-attributed hearing loss is the main reason for surgical intervention in children with COME [20]. However, our study shows that other ear-related symptoms like disrupted sleep and earache also affect children suffering from OM. According to our data, TT insertion has a significant effect on these and other ear-related symptoms. Most children experienced symptom relief already one month after TT insertion; a prompt change pointing towards a real effect of TT insertion rather than spontaneous symptom relief associated with the self-limiting nature of OM. Although these specific QOL variables are not current indications for TT insertion in children with OM, they could very well be the main reason why the Danish TT insertion frequency ranks highest in the world. We therefore suggest that symptoms like sleep disruption and earache are important variables when reporting the results of TT insertion in future investigations.

Our study did not include a control group, and our observations need to be confirmed in a randomised trial. However, as TT insertion has been well established in Denmark for decades, a randomised trial will be difficult to conduct in a Danish private ENT specialist setting.

CONCLUSIONS

Our main findings underpin a high degree of short-term symptom relief following TT insertion in children with OM under the age of 12 years. We also found a persistently high percentage of parents who were satisfied with TT insertion in their child throughout the 12-month observation period. Finally, in this setting, ePRO data proved to be a promising tool for the assessment of treatment outcome in children undergoing TT insertion.

CORRESPONDENCE: Lene Dahl Siggaard.
E-mail: lenedahlsiggaard@gmail.com

ACCEPTED: 1 July 2019

CONFLICTS OF INTEREST: none. Disclosure forms provided by the authors are available with the full text of this article at www.danmedj.dk.

ACKNOWLEDGEMENTS: We express our gratitude to the private practicing ENT specialists Pascal Bonvin, Mikkel Bruun, Janus Jespersen, Peder Frandsen, Christian Bak, Jakob Korsholm Nielsen, Jonas Peter Holm, Thomas Qvist Barrett, Malene Sine Rokkjær, Michael Lüscher, Jette Berg, Bo Karlsmose, Andreas Agger, Torben Lilholt/Rikke Haahr, Berit Svenstrup, Pia Juul, Lotte Jung, Peter Koefoed Tingsgaard, Liviu Guldfred, Kim Werther, Tomaas Ravn, Ann- Reventlow-Mourier, Anders Schermacher, Christian Prætorius, Roland Welinder and Mikkel Holmelund, in the pilot clinics for their implementation of patient registration in the database. We also greatly appreciate our collaboration with the Danish ENT Specialists Organisation, DØNHO, the Unit of Quality in Specialist Practice, eKVIS, and the Fund for Professional Development in Specialist Practice for supporting the implementation of the DØNHO database.

Bib ref: 
Dan Med J 2019;66(9):A5567
Magazine: 
Page number: 

LITERATURE

  1. Todberg T, Koch A, Andersson M et al. Incidence of otitis media in a contemporary Danish national birth cohort. PLoS ONE 2014;9:e111732.

  2. Lieberthal AS, Carroll AE, Chonmaitree T et al. The diagnosis and management of acute otitis media. Pediatrics 2013;131:e964-e999.

  3. American Academy of Family Physicians; American Academy of Otolaryngology-Head and Neck Surgery; American Acade my of Pediatrics Subcomittee on Otitis Media with Effusion. Otitis media with effusion. Pediatrics 2004;113:1412-29.

  4. Paradise JL, Feldman HM, Campbell TF et al. Tympanostomy tubes and developmental outcomes at 9 to 11 years of age. N Engl J Med 2007;356:248-61.

  5. Hellström S, Groth A, Jörgensen F et al. Ventilation tube treatment: A systematic review of the literature. Arch Otolaryngol Head Neck Surg 2011;145:383-95.

  6. Steele DW, Adam GP, Di M et al. Effectiveness of tympanostomy tubes for otitis media: A meta-analysis. Pediatrics 2017;139:e20170125.

  7. Grindler DJ, Blank SJ, Schulz KA, et al. Impact of otitis media severity on childrens’ quality of life. Arch Otolaryngol Head Neck Surg 2014;151:333-40.

  8. Kujala T, Alho OP, Kristo A et al. Quality of life after surgery for recurrent otitis media in a randomized controlled trial. Pediatr Infect Dis J 2014;33:715-9.

  9. Kluetz PG, O’Conner DJ, Soltys K. Incorporating the patient experience into regulatory decision making in the USA, Europe, and Canada. Lancet Oncol 2018;19:e267-74.

  10. Tingsgaard JK, Tingsgaard PK, Siggaard LD et al. Validation of the
    Danish National Tympanostomy tube Insertion Questionnaires (DANTIQ) measuring symptoms, treatment effect and adherence to guidelines. Dan Med J 2019;66(9):A5568.

  11. Coons SJ, Eremenco S, Lundy JJ et al. Capturing patient-reported outcome (PRO) data electronically: the past, present and promise of ePRO measurement in clinical trials. Patient 2015;8:301-9.

  12. Holch P, Warringon L, Bamforth LCA et al. Development of an intergrated electronic platform for patient self-report and management of adverse events during cancer treatments. Ann Oncol 2017;28:2305-11.

  13. Johansen ECJ, Svendstrup B, Schønsted-Madsen U et al. Forældre er tilfredse med drænbehandling af trommehinde i speciallægepraksis. Ugeskr Læger 2010;172:2530-4.

  14. Heidemann CH, Lauridsen HH, Kjeldsen AD et al. Quality-of-life differences among diagnostic subgroups of children receiving ventilating tubes for otitis media. Head Neck Surg 2015;153:636-43.

  15. Heidemann CH, Lous J, Berg J et al. Danish guidelines on management of otitis media in preschool children. Int J Pediatr Otorhinolaryngol 2016;87:154-63.

  16. Rosenfeld RM, Pynnonen MP, Hussey HM et al. Clinical practice guideline: tympanostomy tubes in children. Otolaryngol Head Neck Surg 2013;149:1-35.

  17. NICE, National Institute for Health and Clinical Excellence, Surgical Management of Otitis Media with Effusion, 2008. https://www.nice.org.uk/guidance/cg60/documents/cg60-surgical-management-of-ome-full-guideline2 (1 Dec 2018).

  18. Berkman ND, Wallace IF, Steiner MJ et al. Otitis media with effusion: comparative effectiveness of treatments. Rock-ville (MD): Agency for Healthcare Research and Quality, 2013. (Comparative Effectiveness Review No. 101). https://effectivehealthcare.ahrq.gov/sites/default/files/pdf/ear-infection_research.pdf (1 Dec 2018).

  19. Hall AJ, Maw AR, Steer CD. Developmental outcomes in early compared with delayed surgery for glue ear up to age 7 years: a randomised controlled trial. Clin Otolaryngol 2009;34:12-20.

  20. Simon F, Haggard M, Rosenfeld RM et al. International consensus (ICON) on management of otitis media with effusion in children. Eur Ann Otorhinolaryngol Head Neck Dis 2018;135:33-9.

💬 0 Comments

Add new comment